YBX1 and osteosarcoma: In osteosarcoma, VEGF165 promotes tumor progression, while VEGF165b opposes it; YBX1, a critical splicing factor, upregulates VEGF165 but downregulates VEGF165b, impacting both their levels and the disease course [206].